Literature DB >> 6985785

Peritonitis during continuous ambulatory peritoneal dialysis.

J Rubin, W A Rogers, H M Taylor, E D Everett, B F Prowant, L V Fruto, K D Nolph.   

Abstract

We initiated a therapeutic program of continuous ambulatory peritoneal dialysis for patients with chronic renal failure. Our program resulted in many episodes of peritonitis arising from contamination due to the technical aspects of the procedure. Microbiologic evaluation showed that 73% of 97 episodes were culture positive, with gram-positive organisms causing most of the cases, especially early in dialysis. Gram-negative rods tended to occur later. Gram stains of dialysate effluent resulted in a disappointingly low yield of only 9% positivity. Cell counts were a dependable indicator of the presence of peritoneal inflammation and also of therapeutic success. Most patients responded well to intraperitoneal cephalothin, 125 mg/L for 10 to 14 d. The occurrence of peritonitis resulted in 0.93 years of hospitalization during the total of 15.45 patient-years on dialysis, which essentially negated the financial advantages of this method of treatment of chronic renal failure. For this to be a successful mode of therapy, advances in the prevention of peritonitis must be made.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6985785     DOI: 10.7326/0003-4819-92-1-7

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  60 in total

1.  Continuous ambulatory peritoneal dialysis-related peritonitis associated with Lancefield group G beta-hemolytic streptococcus: report of two cases requiring Tenckhoff catheter removal.

Authors:  Patrick C Y Woo; Samson S Y Wong; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R H Barbhaiya; C A Knupp; M Pfeffer; D Zaccardelli; G M Dukes; W Mattern; K A Pittman; L J Hak
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 3.  Infections associated with indwelling devices: infections related to extravascular devices.

Authors:  G M Dickinson; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 4.  Peritoneal catheters and related infections.

Authors:  Elias Thodis; Ploumis Passadakis; Nikolaos Lyrantzopooulos; Stelios Panagoutsos; Vassilis Vargemezis; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Flavimonas oryzihabitans (formerly CDC group Ve-2) bacteremia in a pediatric patient on assisted ventilation.

Authors:  J Reina; J Odgardd; I Llompart; P Alomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

6.  Evaluation of isolator system and large-volume centrifugation method for culturing body fluids.

Authors:  H R Elston; M Wang; A Philip
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

7.  Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

Authors:  H A Verbrugh; W F Keane; W E Conroy; P K Peterson
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

8.  Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  S Pancorbo; C Comty
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

9.  Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.

Authors:  W Zimmerli; P D Lew; F A Waldvogel
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.

Authors:  P Somani; E H Freimer; M L Gross; J T Higgins
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.